H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 54 Citations 9,399 110 World Ranking 1657 National Ranking 692

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Genetics
  • Malaria

Peter A. Zimmerman mainly focuses on Malaria, Immunology, Virology, Genetics and Plasmodium vivax. The study incorporates disciplines such as Epidemiology, Parasitology and Drug resistance in addition to Malaria. His Immunology research integrates issues from Acquired immunodeficiency syndrome, Cohort and Haplotype.

His Virology study combines topics from a wide range of disciplines, such as Antibody, Polymerase chain reaction and Plasmodium. Genetics is represented through his Allele, Genotype, Gene and Genotyping research. His Plasmodium vivax research incorporates themes from Infectious disease, Parasitemia and Antigen.

His most cited work include:

  • CCR5 promoter polymorphism and HIV-1 disease progression (360 citations)
  • CCR5 promoter polymorphism and HIV-1 disease progression (360 citations)
  • Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people (282 citations)

What are the main themes of his work throughout his whole career to date?

Peter A. Zimmerman focuses on Malaria, Plasmodium falciparum, Immunology, Genetics and Virology. Peter A. Zimmerman combines subjects such as Epidemiology, Parasitology and Polymerase chain reaction with his study of Malaria. The various areas that Peter A. Zimmerman examines in his Plasmodium falciparum study include Tropical medicine and Drug resistance.

His work deals with themes such as Acquired immunodeficiency syndrome, Cohort and Genotype, which intersect with Immunology. His research related to Allele, Haplotype, Gene, Single-nucleotide polymorphism and Genotyping might be considered part of Genetics. His Virology research includes elements of Plasmodium ovale, Plasmodium malariae, Gametocyte, Antibody and Apicomplexa.

He most often published in these fields:

  • Malaria (49.16%)
  • Plasmodium falciparum (35.75%)
  • Immunology (33.52%)

What were the highlights of his more recent work (between 2014-2021)?

  • Malaria (49.16%)
  • Plasmodium vivax (25.14%)
  • Genetics (35.20%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Malaria, Plasmodium vivax, Genetics, Virology and Plasmodium falciparum. His Malaria study results in a more complete grasp of Immunology. Peter A. Zimmerman has included themes like Allele and Haplotype in his Immunology study.

His biological study spans a wide range of topics, including CYP2D6, Genotype and Primaquine. The Virology study combines topics in areas such as Genetic diversity, Antigen, Rapid diagnostic test, Antibody and Polymerase chain reaction. His research integrates issues of Amplicon and Parasitology in his study of Plasmodium falciparum.

Between 2014 and 2021, his most popular works were:

  • Development of a Single Nucleotide Polymorphism Barcode to Genotype Plasmodium vivax Infections (92 citations)
  • Acquisition of Antibodies against Plasmodium falciparum Merozoites and Malaria Immunity in Young Children and the Influence of Age, Force of Infection, and Magnitude of Response (82 citations)
  • PLASMODIUM VIVAX TRANSMISSION IN AFRICA (66 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Genetics
  • Malaria

His primary areas of study are Malaria, Plasmodium vivax, Plasmodium falciparum, Plasmodium and Environmental health. His studies in Malaria integrate themes in fields like Veterinary medicine and Virology. Much of his study explores Plasmodium vivax relationship to Genetics.

His Plasmodium falciparum study deals with the bigger picture of Immunology. His Plasmodium research is multidisciplinary, incorporating perspectives in Adaptation, Whole genome sequencing and Genomics. His biological study deals with issues like Epidemiology, which deal with fields such as Central Highlands and Plasmodium species.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

CCR5 promoter polymorphism and HIV-1 disease progression

David H McDermott;Peter A Zimmerman;Peter A Zimmerman;Florence Guignard;Cynthia A Kleeberger.
The Lancet (1998)

550 Citations

Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people

Didier Ménard;Céline Barnadas;Christiane Bouchier;Cara Henry-Halldin.
Proceedings of the National Academy of Sciences of the United States of America (2010)

383 Citations

Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations.

Alexander Gerd. Maier;Manoj T. Duraisingh;John C. Reeder;Sheral S. Patel.
Nature Medicine (2003)

381 Citations

Plasmodium malariae and Plasmodium ovale – the ‘bashful’ malaria parasites

Ivo Mueller;Peter A. Zimmerman;John C. Reeder.
Trends in Parasitology (2007)

331 Citations

The global distribution of the Duffy blood group.

Rosalind E. Howes;Anand P. Patil;Frédéric B. Piel;Oscar A. Nyangiri.
Nature Communications (2011)

301 Citations

R5 HIV productively infects langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms

Tatsuyoshi Kawamura;Forrest O. Gulden;Makoto Sugaya;David T. McNamara.
Proceedings of the National Academy of Sciences of the United States of America (2003)

265 Citations

Epidemiologic and Biologic Characterization of a Cohort of Human Immunodeficiency Virus Type 1 Highly Exposed, Persistently Seronegative Female Sex Workers in Northern Thailand

Chris Beyrer;Andrew W. Artenstein;Sungwal Rugpao;Henry Stephens.
The Journal of Infectious Diseases (1999)

262 Citations

Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea.

Peter A. Zimmerman;Ian Woolley;Godfred L. Masinde;Stephanie M. Miller.
Proceedings of the National Academy of Sciences of the United States of America (1999)

249 Citations

Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort study

David H. McDermott;Matthew J. Beecroft;Cynthia A. Kleeberger;Fadwa M. Al-Sharif.
AIDS (2000)

245 Citations

Comparing the Ex Vivo Fitness of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates of Subtypes B and C

Sarah C. Ball;Awet Abraha;Kalonji R. Collins;Andre J. Marozsan.
Journal of Virology (2003)

242 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter A. Zimmerman

Ivo Mueller

Ivo Mueller

Walter and Eliza Hall Institute of Medical Research

Publications: 342

Peter Siba

Peter Siba

Papua New Guinea Institute of Medical Research

Publications: 104

James G. Beeson

James G. Beeson

Burnet Institute

Publications: 100

Ric N. Price

Ric N. Price

Charles Darwin University

Publications: 87

Ingrid Felger

Ingrid Felger

Swiss Tropical and Public Health Institute

Publications: 76

Alan F. Cowman

Alan F. Cowman

Walter and Eliza Hall Institute of Medical Research

Publications: 74

Alyssa E. Barry

Alyssa E. Barry

Deakin University

Publications: 71

François Nosten

François Nosten

MORU Mahidol Oxford Tropical Medicine Research Unit

Publications: 60

Dominic P. Kwiatkowski

Dominic P. Kwiatkowski

Wellcome Sanger Institute

Publications: 58

Freya J. I. Fowkes

Freya J. I. Fowkes

Burnet Institute

Publications: 57

Jetsumon Sattabongkot

Jetsumon Sattabongkot

Mahidol University

Publications: 52

Christopher L. King

Christopher L. King

Case Western Reserve University

Publications: 49

John H. Adams

John H. Adams

University of South Florida

Publications: 49

Chetan E. Chitnis

Chetan E. Chitnis

Institut Pasteur

Publications: 49

Julian C. Rayner

Julian C. Rayner

University of Cambridge

Publications: 46

Teun Bousema

Teun Bousema

Radboud University Nijmegen

Publications: 46

Something went wrong. Please try again later.